Andrew Deavin, PhD GSK Vaccines

Andrew Deavin has spent over 20 years in Regulatory Affairs operating in the UK, Europe and International. He has managed regulatory projects in development, registration and life-cycle primarily in vaccines but also in haematology/oncology. Latterly, Andrew has focussed on International particularly China and Asia Pacific. In this role, he resolves internal vaccine regulatory issues and works externally on the regulatory environment to reduce complexity. This includes active involvement in various industry associations.

He leads the EFPIA ‘Korea & Taiwan’ regulatory network, is a member of EFPIA’s International Regulatory Expert Group (IREG) and sits on EFPIA and IFPMA regulatory sub-teams focussed upon lifecycle management. He currently works for GSK Vaccines and is based in Belgium.